Downregulation of 4-HNE and FOXO4 collaboratively promotes NSCLC cell migration and tumor growth.
Tianfei ZhongYing LiMeng JinJingqun LiuZhenyu WuFeiye ZhuLisha ZhaoYongsheng FanLi XuJinjun JiPublished in: Cell death & disease (2024)
Non-small cell lung cancer (NSCLC) is among the most prevalent cancers and a leading cause of cancer-related mortality globally. Extracellular vesicles (EVs) derived from NSCLC play a pivotal role in lung cancer progression. Our findings reveal a direct correlation between the abundance of EVs and the transfection efficiencies. Co-culturing two different lung cancer cell lines could enhance EVs formation, cell proliferation, migration and tumorigenicity. mRNA chip and metabolic analyses revealed significant alterations in the FOXO signaling pathway and unsaturated fatty acid metabolism within tumor tissues derived from co-cultured cells. Shotgun lipidomics studies and bioinformatics analyses guided our attention towards 4-Hydroxynonenal (4-HNE) and FOXO4. Elevating 4-HNE or FOXO4 levels could reduce the formation of EVs and impede cell growth and migration. While silencing FOXO4 expression lead to an increase in cell cloning rate and enhanced migration. These findings suggest that regulating the production of 4-HNE and FOXO4 might provide an effective therapeutic approach for the treatment of NSCLC.
Keyphrases
- signaling pathway
- pi k akt
- induced apoptosis
- small cell lung cancer
- transcription factor
- cell proliferation
- cell cycle arrest
- advanced non small cell lung cancer
- cell migration
- single cell
- fatty acid
- epithelial mesenchymal transition
- working memory
- cardiovascular disease
- brain metastases
- type diabetes
- genome wide
- high throughput
- coronary artery disease
- cell therapy
- risk factors
- cardiovascular events
- bone marrow
- young adults
- combination therapy
- smoking cessation
- replacement therapy